Matthew H. Wilson

Physician-scientist at Vanderbilt engineering cell and gene therapies for kidney disease. Views are my own.

[Matthew H. Wilson @MattWilsonLab]

@samirparikhmd @UTSWMedCenter @UTSWInternalMed Congrats Samir! Well deserved and I know you’ll continue to do great things!

[Matthew H. Wilson @MattWilsonLab]

Congratulations to @JenPeekMSTP on successfully defending her PhD dissertation yesterday! Well done. @VanderbiltMSTP @VanderbiltCDB

[Matthew H. Wilson @MattWilsonLab]

@WashUNephrology @LeslieGewin Congratulations Leslie, well deserved!

[Matthew H. Wilson @MattWilsonLab]

@katy_beckermann Congratulations Katy!

[Matthew H. Wilson @MattWilsonLab]

Congratulations to Jen Peek @JenPeekMSTP for being awarded one of the top trainee presentations at the ASN meeting! @ASNKidney @VanderbiltMSTP @VUMCKidney

[Matthew H. Wilson @MattWilsonLab]

We must milk this for all it’s worth!

[SEC Shorts @SECShorts]

Vandy beats #1 Alabama.

presented by: @renasant

[Matthew H. Wilson @MattWilsonLab]

Wow! Anchor down! Go Vanderbilt!

[Jen Peek @JenPeekMSTP]

@MattWilsonLab @LEWoodardPhD undergraduates Julie and Jack did amazing jobs showing off their research today at @SEmdphd! The future of physician scientists is certainly bright with these two rock stars ✨

[VU Chemical Biology @VICB_Vanderbilt]

.@VanderbiltU @VUMCResearch investigators Chuck Sanders & @roy_zent garner $1.2M Keck Foundation grant for groundbreaking genetic research project: “Genetic Intolerance Patterns as a Treasure Map to Genes that Define Us as Human”
@VUBasicSciences

https://t.co/OFYBkHFSQ7

[Matthew H. Wilson @MattWilsonLab]

@LeslieGewin Your lab is growing!

[Lauren E. Woodard @LEWoodardPhD]

Curious about nonviral vectors for gene therapy? Come to my ASGCT lunch & learn online tomorrow at noon CST! You bring the lunch, I bring the learn.

Register here for free:

https://t.co/Rz1J8ARXDr

[Cell Therapy News @celltherapynews]

🥂 Drs. @MattWilsonLab and @JenPeekMSTP from @VanderbiltCDB review the potentials of cell and #GeneTherapy for kidney diseases, focusing on recent studies, key advances, and emerging technologies!

Congratulations to the dynamic duo 👯!

@NatRevNep | https://t.co/TyD2SofzYF

[Matthew H. Wilson @MattWilsonLab]

Forgot the link! https://t.co/Ue5kZ45g8L

[Matthew H. Wilson @MattWilsonLab]

Congrats to @JenPeekMSTP on coauthoring “Cell and gene therapy for kidney disease” with me in @NatRevNeph! Looking forward to new therapies for kidney patients in the near future. @VUMCKidney @VanderbiltMSTP @VanderbiltCDB @ASGCTherapy @VandyPharm

[Matthew H. Wilson @MattWilsonLab]

@LErtuglu @VUMCMedicineRes Congrats Lale! @VUMCKidney

[Lou P Henle @HenleLou]

I feel like if you are consulting both palliative care and nephrology at the same time, epic should have a safety catch and make you only choose one.

[Juan Carlos Q Velez @VelezNephHepato]

Completing annual online modules

[Matthew H. Wilson @MattWilsonLab]

@merrymanlab Congrats!

[Matthew H. Wilson @MattWilsonLab]

@JenPeekMSTP @VUMCKidney You guys are awesome!

[Lauren E. Woodard @LEWoodardPhD]

Join me for the Insight Series:

Latest Research and Ethical Considerations for Targeted Insertion of Genes into the Human Genome

co-moderated with Thomas Wechsler

December 7, 2022 | 1 - 3 p.m. CT

#ASGCT members register free!

@lecong @samira_kiani1

https://t.co/Y3h6AnKcTr